© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Supply Chain
The Pharma Supply Chain Post-COVID-19: Key Lessons and Opportunities
August 31, 2020
Ferdi Steinmann outlines a few supply chain lessons that all pharma companies can learn from the COVID-19 pandemic.
The Pharma Supply Chain: Responding to COVID-19
July 01, 2020
Taking stock of evolving practices in protecting the supply chain amid the pandemic, including partnering and planning for what’s next.
What You Need to Know about the Drug Supply Chain Security Act
March 18, 2020
It is vital to begin asking questions about your company’s DSCSA readiness and compliance, as well as that of your strategic partners, writes Rob Besse.
Tackling Drug Shortages through Robust Supply Chains
March 12, 2020
MilliporeSigma's Robert McGuirk speaks with Pharma Exec about the role of supply chain robustness in helping to mitigate the risk of drug shortages
Policy Sync-Up: The Drug Importation Conundrum
October 08, 2019
Coexisting with the DSCSA may hinder new legislative efforts.
High-Stakes Manufacturing: Mitigating the Risks
August 08, 2019
How to navigate the production and reimbursement intricacies of bringing regenerative medicines from bench to bedside.
Real-Time Information across the Pharma Supply Chain
February 08, 2019
Tim Willis and Oliver Wack outline the role of alternative data in supply chain risk management, and the ancillary benefits that come from adopting such technology.
8 Tipping Points: Pharm Exec’s 2019 Industry Forecast
January 23, 2019
Pharm Exec’s annual look at what lies ahead for the biopharma industry in the coming months examines eight key trends that are seemingly at tipping points in their evolution and poised to shape the life sciences landscape in 2019.
In Blockchain We Trust
October 29, 2018
The next generation of supply chain shows an increasing need for blockchain technology.
The ‘Spare-No-Expense’ Alternative
September 13, 2018
How low-cost drugs can succeed in the specialty pharmacy channel.
Specialty Supply Chain Decisions
September 11, 2018
In today’s drug development environment, there is no doubt that supply chain decisions are paramount in a product launch strategy, writes Lisa Henderson.
Blockchain 101 for Pharma Executives
July 09, 2018
With blockchain still in the potential but not proven area of the pharma enterprise, when is the technology the right choice for you?
Shining a Light on Supply Chain Visibility
March 19, 2018
Steve Cottrell assesses the risks of lapses in pharma's supply chain visibility and outlines what can be done to minimize them
Going to the Edge
December 12, 2016
How a Manufacturing Excellence program can deliver competitive advantage to a fast-changing global product mix-at lower cost, and with an unexpected workforce dividend to boot.
Steady Hands: AmerisourceBergen's Peyton Howell
August 15, 2016
Pharm Exec sits down with AmerisourceBergen supply chain leader Peyton Howell to discuss the latest trends in pharmaceutical distribution, including company efforts to boost efficiency, reliability, and enhance its groundbreaking partnership with Walgreens Boots Alliance.
Closing the Gaps in Drug Chain of Custody
April 28, 2016
Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
Supply Chain Integration or Bust… or Both
February 12, 2016
The recent formation of three mega supply-chain purchasing groups (Walgreen’s-AllianceBoots-AmerisourceBergen-Rite-Aid, McKesson-Celesio, CVS-Cardinal) denotes a shift in the balance of power between wholesalers, chains, generic pharmaceutical companies and branded pharma companies.